# Protection by Remote Ischemic Preconditioning During Transcatheter Aortic Valve Implantation

Study · id `cardio:ct-nct02080299` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02080299](<https://clinicaltrials.gov/study/NCT02080299>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02080299

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 100 participants.

## Technical summary

Registry record NCT02080299. Randomized; single masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2017-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT02080299, source copy `cardio:ctgov-nct02080299-2016-11-02`, retrieved 2026-10-26)
- Start date: 2013-09 (registry gives no type) (ClinicalTrials.gov record NCT02080299, source copy `cardio:ctgov-nct02080299-2016-11-02`, retrieved 2026-10-26)
- Primary completion: 2017-08 (anticipated) (ClinicalTrials.gov record NCT02080299, source copy `cardio:ctgov-nct02080299-2016-11-02`, retrieved 2026-10-26)
- Completion: 2017-08 (anticipated) (ClinicalTrials.gov record NCT02080299, source copy `cardio:ctgov-nct02080299-2016-11-02`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT02080299, source copy `cardio:ctgov-nct02080299-2016-11-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02080299-2016-11-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Protection by Remote Ischemic Preconditioning During Transcatheter Aortic Valve Implantation
- Condition: Aortic Valve Stenosis
- Intervention (Procedure): Remote ischemic preconditioning (RIPC)
- Intervention (Procedure): Placebo
- Lead sponsor: University Hospital, Essen
- Lead sponsor class: OTHER
- Collaborator: Koblenz University of Applied Science
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)

## Provenance

Content hash: 8ef27e9acbc80a0d781d850db00527d6ae39a9a15c2aabfc9959a49c326f27c7
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
